Investor Presentaiton
Coordinated Specialty Care (CSC) for Early Serious Mental Illness involving First Episode of Psychosis
Nevada, 2019-2021
Beginning in 2017, the State selected the evidence-based NAVIGATE Early Treatment Program of Coordinated Specialty Care for
First Episode of Psychosis for implementation throughout Nevada. Selection was based on the following factors:
The efficacy and feasibility of the NAVIGATE Early Treatment Program for implementation within community mental health
settings and in rural and low-density population regions in the United States were demonstrated by clinical trial:
Clinical Trials registration: NCT01321177: An Integrated Program for the Treatment of First Episode of Psychosis (RAISE ETP),
http://www.clinicaltrials.gov/ct2/show/NCT01321177
The personalized medicine framework of the NAVIGATE Early Treatment Program, which uses targeted therapies from
multiple specialties to treat a specific diagnostic category of complex and serious mental illness—the schizophrenia
spectrum and other psychotic disorders.
The clinical treatment design of the NAVIGATE Early Treatment Program, which is compatible with an outcomes-driven
methodology for achieving quality control and continuous performance improvement. For example,
medical, psychological and psychosocial assessments are administered continuously (monthly, bi-monthly, quarterly,
annually) to evaluate the clinical and functional status of patients, as well as to monitor the efficacy of specialty care
interventions and the fidelity of program implementation with the evidence-based protocol.
The National NAVIGATE Training Team of experts who were involved in the National Institutes of Health Clinical Trial (RAISE
Research Initiative) were available to provide training, guidance and ongoing consultation to states and community-based
providers in the implementation of the NAVIGATE Early Treatment Program for First Episode of Psychosis.View entire presentation